A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin
Clinical trial NCT01238796 · COMPLETED
Trial details
- NCT number
- NCT01238796
- Sponsor
- Cumberland Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.